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Objective: To assess the impact of a diabetic foot outpatient clinic on reducing the morbidity
of  this disease, with emphasis on lower-limb lesions.
Methods: This was a prospective observational study with a target population of 30 cases
out  of a total of 77 patients in the diabetic foot outpatient clinic. The inclusion criterion was
that  data relating to laboratory tests, clinical examinations, neuropathic and vascular tests
and  the elbow-arm index needed to be available from all the patients, with repetition after
18  months of follow-up, so as to analyze their evolution. The statistical analysis was done
using  the McNemar chi-square test for dependent samples.
Results: The patients’ mean age was 61 years. All of them had type 2 diabetes mellitus (DM),
which  had started 14.5 years previously, on average, and 20% had neuropathies. After 18
months,  there was no change in the frequency of lesions in diabetes target organs (p = 1.000)
or  in the neuropathy rate (p = 1.000). However, there were signiﬁcant improvements in neu-
ropathic symptoms, from 70% to 36.7% (p = 0.035), and in peripheral arterial disease, from
73.3%  to 46.7% (p = 0.021). There was also a decrease in ulcers from 13.3% to 10% (p = 1.000).
Conclusions: Creation of specialized outpatient clinics for prevention of diabetic foot is a
viable investment, which has low cost compared with the high costs generated through the
complications from this disease. This approach noticeably improves the patients’ quality of
life, with reduction of morbidity.© 2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda.  
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Prevenc¸ão  de  lesões  de  membros  inferiores  e  reduc¸ão  da  morbidade  em
pacientes  diabéticos
Palavras-chave:
Diabetes mellitus
Prevenc¸ão  primária
Pé
Neuropatias diabéticas
Doenc¸as  vasculares periféricas
Infecc¸ão
Úlcera
Amputac¸ão
r  e  s  u  m  o
Objetivo: Avaliar o impacto de um ambulatório de pé diabético na reduc¸ão  da morbidade da
doenc¸a,  com ênfase nas lesões dos membros inferiores.
Métodos: Estudo prospectivo, observacional, com populac¸ão  alvo de 30 casos do total
de 77 pacientes do ambulatório de pé diabético. O critério de inclusão foi que todos os
pacientes tivessem exames laboratoriais, exame clínico, testes neuropático e vascular e
índice tornozelo-brac¸o  repetidos após 18 meses de acompanhamento, o que permitiu anal-
isar sua evoluc¸ão.  A análise estatística foi feita com o teste qui-quadrado de MacNemar para
amostras dependentes.
Resultados: A média de idade dos pacientes foi de 61 anos, todos portadores de diabetes
mellitus (DM) tipo 2, iniciada em média havia 14.5 anos, e 20% eram neuropatas. Após 18
meses, não houve mudanc¸a  na frequência de lesão em órgão alvo da diabetes (p = 1000)
e no índice de neuropatia (p = 1000). Obteve-se, no entanto, melhoria signiﬁcativa dos sin-
tomas neuropáticos de 70% para 36.7% (p = 0.035), bem como da doenc¸a  arterial periférica de
73.3% para 46.7% (p = 0.021). Foi observada ainda diminuic¸ão  de 13.3% para 10% das úlceras
(p = 1000).
Conclusões: A criac¸ão  de ambulatórios especializados em prevenc¸ão  do pé diabético é
investimento viável, de baixo custo quando comparado aos altos custos gerados pelas
complicac¸ões  dessa doenc¸a.  Essa abordagem melhora sensivelmente a qualidade de vida
do paciente, com a reduc¸ão  da morbidade.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. 
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iabetes mellitus (DM) causes degenerative complications
hat have human and socioeconomic repercussions and
ave  become an important public health problem.1 Among
hese  complications are lesions in target organs, includ-
ng  retinopathy, nephropathy and accelerated atherosclerosis,
ith  increased risks of myocardial infarction or stroke, and
esions  that affect the feet, which are the most frequent type.2
ccording to the deﬁnition of the International Consensus
n  Diabetic Foot, this condition is understood to consist of
nfection,  ulceration and/or destruction of the deep tissues,
n  association with neurological abnormalities and various
egrees  of peripheral vascular disease in the lower limbs.2
he prevalence of ulcers on the feet of the diabetic popu-
ation  is between 4% and 10%, and 85% of amputations of
he  lower extremities among these patients are preceded
y  ulceration.2 Approximately 40–60% of all non-traumatic
mputations of the lower limbs are performed on diabetic
atients.1,2 Three years after amputation of a lower limb of
 diabetic individual, the percentage survival is 50%, while
ver  a ﬁve-year period, the mortality rate ranges from 39% to
8%.3
One very important factor relating to development of ulcers
n  the feet is the presence of peripheral motor-sensory neu-
opathy,  which has been associated with loss of sensitivity
o  pain and loss of perception of pressure, temperature and
roprioception.4–8 This leads to diminished perception of
ounds  or trauma. Four out of every ﬁve ulcers on diabetic
ndividuals are precipitated by external trauma.2 Furthermore,motor  neuropathy gives rise to atrophy and weakening of the
intrinsic  muscles of the feet and generates deformities such
as  crooked toes and abnormal gait patterns, which evolve to
calluses  and pressure ulcers. Cases of greater severity lead
to  Charcot foot, which is a progressive disease characterized
by  joint displacement, pathological fractures and debilitating
deformities.8,9 Autonomic neuropathy also leads to reduction
or  total absence of sudoriparous secretion and leads to skin
desiccation, with cracks and ﬁssures.8,10
Peripheral vascular disease (PVD) is an important risk
factor  for ulceration and amputation.6,11–13 It results from
atherosclerosis of peripheral arteries, leads to obstruction of
distal  arteries and arterioles, hinders blood ﬂow and deprives
the  tissues of adequate supplies of oxygen, nutrients and
antibiotics, which impairs ulcer healing and may  conse-
quently lead to gangrene.14 Gangrene is four times more
common among individuals with diabetes than in the general
population, and its incidence gradually increases with age and
with  the duration of the disease.15
Ulcers generally result from trivial, mild and repeated
trauma, such as erroneous ﬁt and use of footwear, or even from
walking  barefoot.8,12 Approximately 70–100% of ulcers present
signs  of peripheral neuropathy with varying degrees of PVD.
Infection  is only rarely considered to be the direct cause of
an  ulcer.16 However, infected ulcers present a higher risk of
subsequent  amputation.2
In view of the high costs of ulcers and amputations, both
for  individuals and for society, preventive care for diabetic foot
has a positive effect on the cost–beneﬁt relationship. It has
now  been demonstrated that up to 50% of amputations and
ulcerations  could be prevented through early diagnosis and
p . 2 0 484  r e v b r a s o r t o 
adequate treatment.1,17,18 With this aim in mind, an inter-
disciplinary care program for diabetics (PAID) was  started in
January 2006, by the hypertension, diabetes and obesity con-
trol  clinic of the municipal health department of the city where
this  study was  conducted. This program promotes specialized
multidisciplinary follow-up for diabetic patients and aims to
educate patients and to implement prevention and early diag-
nosis  and treatment of lesions in target organs.
Objective
To evaluate the impact of the PAID diabetic foot outpatient
clinic  for reducing morbidity among diabetic patients, with
emphasis  on lower-limb lesions.
Materials  and  methods
The present study was  approved by the institution’s research
ethics  committee under protocol no. 1437.128.2008. It had
support  from the National Council for Scientiﬁc and Techno-
logical  Development (CNPq) through its institutional program
for  scientiﬁc initiation bursaries. This was  a prospective obser-
vational  study on cases, with a target population formed by 30
of  the 77 patients of the PAID diabetic foot outpatient clinic.
These  patients were  recruited spontaneously among those
who,  by April 2011, after 18 months of follow-up, had under-
gone  complete repetition of their initial clinical and laboratory
tests.
The  participants in this study were over the age of 18 years,
without  distinction regarding sex or ethnicity. They were free
to refuse to participate at any time, without any modiﬁcation
in  the way  in which they were  attended by the researcher. Con-
ﬁdentiality and privacy were  guaranteed. A free and informed
consent  statement was  signed by all participants.
All individuals who  did not agree to participate were
excluded, as were  all those who  did not participate in the
entire  clinical and laboratory reevaluation performed after 18
months  of follow-up.
The  multiprofessional PAID team is composed of a vascular
surgeon, an endocrinologist, a dermatologist, a nephrologist, a
psychologist and a nutritionist. All the patients were followed
up  and were  referred to cardiologists, orthopedists or oph-
thalmologists working for the municipal authority, whenever
necessary.
Description of the functioning of the PAID diabetic foot out-
patient  clinic:
1.  Initial medical evaluation, with peripheral neurologi-
cal clinical tests (diabetic neuropathy was  classiﬁed in
accordance with the Portuguese-language versions of the
Neuropathic Symptom Score and Neuropathic Impairment
Score  devised by Moreira et al.19) and arterial evaluation
by means of the ankle-brachial index (ABI) (systolic arte-
rial  pressure of the ankle divided by the systolic arterial
pressure of the arm, both measured with the patient in
the  supine position, using a portable Doppler device).2 Rep-
etition  of the neurological and vascular tests 18 months
later.1 4;4 9(5):482–487
2. Laboratory tests.
3.  Return visits were  scheduled in accordance with the
international diabetic foot consensus and the practical
guidelines for management and prevention of diabetic foot
(2007):  annual returns, if neuropathy was  absent; half-
yearly  returns, if neuropathy was  present; three-monthly
returns, if neuropathy was  present in association with
signs  of peripheral vascular disease and/or deformities of
the  feet; or between every one and three months in cases
of  amputation or previous ulceration.1
4. The patients were systematically advised regarding care to
be  taken for avoiding lesion formation. For this, talks were
given  periodically, leaﬂets were  distributed and guidance
was  given during consultations.
5.  The wounds were treated on an outpatient basis. In cases
of  infected wounds that were greater than 2 cm in diameter
or  showed clinical signs of sepsis, the patients were sent to
a  referral hospital.
The  data were  entered into the Epi Info software (ver-
sion  3.5.1). Statistical comparisons were made using the
McNemar  chi-square test for dependent samples, when the
variables  were  categorical; or using the Student’s t test for
dependent  samples, when the variables were  of numerical
type.  P-values < 0.05 were considered signiﬁcant. The statis-
tical  analysis was  performed using the SPSS software, version
15.
Results
Seventy-seven patients participated in the ﬁrst evaluation of
the  study, on the day when they were ﬁrst registered at the
outpatient  clinic. There were 33 males (42.9%) and 44 females
(57.1%).  Of these, 30 underwent complete repetition of the ini-
tial  set of neurological and vascular tests and laboratory tests,
after  18 months of follow-up.
Thirteen of these were  male (43.3%) and 17 were  female
(56.7%), and all of them presented type 2 DM,  which
had started on average 14.5 years earlier. The patients’
mean age was  61 years and the standard deviation was
9.01.
At  the ﬁrst evaluation, four patients (13.3%) were seen
to  have undergone previous amputation. Amputation of the
fourth  toe of the right foot of one patient was seen at the
second  evaluation.
Some  type of lesion in a target organ (heart, kidney, retina
or  microvasculature of the feet) was  seen in 90% of the
patients, and the frequency of this did not change after 18
months  (p = 1.000). The rates of cardiac diseases (40%; n = 12)
and  renal diseases (23.3%; n = 7) did not change (p = 1.000),
while  retinopathy showed a non-signiﬁcant increase from
53.3%  (n = 16) to 63.3% (n = 19) (p = 0.453). Furthermore, the
patients  did not present any occurrences of stroke and/or
acute  myocardial infarction over this period.
Tables 1–6 present the results relating to the data evaluated
in  this study.Over  the 18-month period, the patients did not present any
signiﬁcant  alterations in palpation of the pulse in the lower
limbs  (p = 1.000).
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Table 1 – Perception of the capacity for self-care of the feet (n = 30).
First evaluation Second evaluation p
Ab Fr R Fr (%) Ab Fr R Fr (%)
Full self-care 22 73.3 12 40.0 0.004
Partial self-care 7 23.3 17 56.7
Inability  to perform self-care 1 3.3 1 3.3
Ab Fr = absolute fraction; R Fr = relative fraction.
Table 2 – Clinical examinations on the feet (n = 30).
First evaluation Second  evaluation p
Ab Fr R Fr (%) Ab Fr R Fr (%)
Previous ulcer 14 46.7 15 50.0 1.000
Amputation 4 13.3 5 16.7 1.000
Deformity of the feet 6 20.0 6 20.0 1.000
Nail mycosis 19 63.3 15 50.0 0.125
Mycosis between toes 14 46.7 5 16.7 0.012
Active ulcer 4 13.3 3 10.0 1.000
Cracks 3 10.0 3 10.0 1.000
Use of appropriate footwear 14 46.7 25 83.3 0.013
Table 3 – Neuropathic sign score19 (n = 30).
First evaluation Second evaluation p
Ab Fr R Fr (%) Ab Fr R Fr (%) p = 0.102
Normal 24 80.0 19 63.3
Mild 3 10.0 7 23.3
Moderate 3 10.0 4 13.3
Table 4 – Neuropathic impairment symptom score19 (n = 30).
First evaluation Second evaluation p
Ab Fr R Fr (%) Ab Fr R Fr (%) p = 0.035
Normal 3 10.0 8 26.7
Mild 6 20.0 11 36.7
Moderate 17 56.7 7 23.3
Severe 4 13.3 4 13.3
Table 5 – Diagnosis of diabetic neuropathy according to the combination indicated by Moreira et al.19 between the
neuropathic symptom score and the neuropathic impairment score (p = 1.000).
First evaluation Second evaluation p
Ab Fr R Fr (%) Ab Fr R Fr (%) p = 1.000
Neuropathic patients 6 20.0 6 20.0
Non-neuropathic patients 24 80.0 24 80.0
Table 6 – Peripheral arterial disease based on the ankle-brachial index (ABI) (n = 30).
First evaluation Second evaluation p
Ab Fr R Fr (%) Ab Fr R Fr (%)
Normal: 0.91–1.30 8 26.7 13 43.3 0.129
Mild obstruction: 0.70–0.90 8 26.7 6 20.0
Moderate obstruction: 0.40–0.69 8 26.7 5 16.7
Poorly reduced: >1.30 6 20.0 6 20.0
Abnormal ABI: <0.90 or >1.30 22 73.3 17 46.7 0.021
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Discussion
It has been well established that 85% of the problems
resulting from diabetic foot can be presented through spe-
cialized  care2,7,8,12,20,21 and that up to 50% of amputations
and ulcerations can be presented through early diagnosis
and  appropriate treatment.1,17,18 Identiﬁcation and classi-
ﬁcation of patients who are at risk (such as those with
diabetic neuropathy, peripheral arterial disease and structural
deformities),2 early aggressive treatment and individual, fam-
ily  and community education form a solid basis for preventing
limb  amputation.22 These actions were targeted in the PAID
diabetic  foot outpatient clinic.
Out of the 30 patients who participated in the study, 90%
presented some type of lesion in a target organ (heart, kidney,
retina  or microvasculature of the feet), and the frequency of
these  lesions remained unchanged 18 months later (p = 1.000).
This  shows that caring for the whole patient should form part
of  the approach.23
After 18 months of follow-up at the PAID diabetic foot
outpatient clinic, the perception regarding the full condi-
tions  of self-care of the feet (Table 1) varied from 73.3%
at  the ﬁrst evaluation to 40% at the second, and the per-
ception  regarding the capacity for partial self-care varied
from  23.3% to 56.7%, which indicates that a signiﬁcant num-
ber  of patients (p = 0.004) perceived that they would need
specialized follow-up in order to receive the appropriate pre-
ventive  and/or curative treatment. Diabetic patients who do
not adhere to their treatment have a 50-fold greater chance of
ulceration  of the foot and a 20-fold greater chance of having
to  undergo amputation than those who  follow the guidance
correctly.24 One study demonstrated that 22 out of 23 ampu-
tations  below the knee were performed on patients who had
never  received any information about therapeutic care or pre-
ventive measures.2
At the start of the follow-up, 46.7% of the patients were
using  appropriate footwear. Eighteen months later, 83.3%
were  using appropriate footwear (p = 0.013) (Table 2). Inap-
propriate  footwear predisposes the feet to extrinsic trauma
and  is considered to be a precipitating factor for ulcera-
tion  of the feet.25 Many  studies have demonstrated that
when  protective footwear is available, prevention of ulcer
recurrence is achieved in 60–85% of the patients.2 The ideal
footwear  reduces the pressure on the feet to below the
threshold for ulceration. Footwear and its insoles should
be  inspected frequently and exchanged when necessary.
If  the footwear that is habitually used cannot be adapted
because of orthopedic deformities or lesions due to exces-
sive  contact area, manufacture of special footwear should be
indicated.5,8,11,13,21
After 18 months, the rate of mycosis between the toes
had  reduced from 46.7% to 16.7% (p = 0.012), nail mycosis had
diminished  from 63.3% to 50% (p = 0.125) and the crack rate
remained  at 10% (Table 2). In one study, mycosis between the
toes  was  considered to be responsible for 20.8% of the ulcers
of  the feet, onychomycosis for 52.5%, calluses and cracks for
49.5%,  dried and ﬂaking skin for 63.4% and nail cleanliness
and  improper nail cutting for 73.3%.26 Basic hygiene mea-
sures  such as properly washing the feet and drying them1 4;4 9(5):482–487
carefully,  using hydrating cream or oil and cutting the nails
properly  and not excessively closely (to be done by a chi-
ropodist) avoids the appearance of these triggering factors for
diabetic foot, and such measures are systematically imple-
mented  at PAID.27
In the initial evaluation, 13.3% of the patients had a history
of  amputation and 46.7% had previously had an ulcer, which
had  been cured (Table 2). This is a high number of patients with
histories  of high risk of amputation according to the risk clas-
siﬁcation  of the international diabetic foot consensus.1 Over
the  18-month follow-up, the number of patients with active
ulcers  decreased from four (13.3%) to three (10.0%), which
demonstrates that the objective of preventing the appearance
of  new ulcers was achieved. After these 18 months, it was  seen
that  only one amputation had been performed: the fourth toe
of the right foot of one patient (3.4%). Thus, the ﬁnal evalu-
ation  showed that ﬁve patients had histories of amputation
(16.7%). This was an excellent result, in comparison with the
literature,  in which amputation rates of around 43–85% have
been  reported among patients undergoing multidisciplinary
approaches.1,2,12
In making the diagnosis of neuropathy, which is an impor-
tant  risk factor for development of ulceration on the feet,2,4–8
the criteria of Moreira et al.19 were used (Tables 3–5). At PAID,
20%  of the patients presented neuropathies (Table 5), and
this  proportion did not increase over the 18-month period
(p  = 1.000). This ﬁnding is important, given that when periph-
eral  neuropathy becomes established, it is irreversible.28,29
Therefore, it is important for individuals with a recent diag-
nosis  to have adequate control over the risk factors, and
for  prophylaxis to be implemented for individuals without
risk  factors, such as rigorous control over blood glucose
levels, guidance regarding smoking and alcohol consump-
tion,  and control over arterial hypertension, dyslipidemia and
vasculopathy.30
With the treatment implemented at PAID, signiﬁcant
improvements in the symptoms of peripheral neuropathy
were observed (p = 0.035) (Table 4). There was a decline in the
proportion  of patients with moderate to severe symptoms,
from  70% to 36.7% over the 18-month period. There was  a
non-signiﬁcant decrease in the number of patients with signs
of  diabetic neuropathy at normal levels, from 80% to 63.3%
(p  = 0.102) (Table 3), which shows that it was  easier to reverse
the  symptoms (which reﬂect an earlier stage of neuropathy)
than the signs (which represent a more  advanced stage of
neuropathy).19
Distal perfusion is another important risk factor for ulcer-
ation  and amputation.2,6,11–13 Over the 18-month period, our
patients did not present any statistically signiﬁcant changes
in  palpation of the lower-limb pulse. However, there was  a
signiﬁcant  improvement in the ABI (p = 0.021), since the inci-
dence  of peripheral arterial disease decreased from 73.3% to
46.7%  according to this index (ABI < 0.90 or > 1.30) (Table 6). This
improvement  can be attributed to the appearance of collateral
circulation, probably resulting from treatment consisting of
regular  walks, controlling the risk factors (such as systemic
arterial  hypertension and dyslipidemia), changes in habits
(such  as elimination of smoking and controlling the diet) and
use  of statins, platelet antiaggregants and hemorheological
drugs.30
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